Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance | Zendy

Samantha Kaufhold | Zendy; Reza Yaesoubi | Zendy; Virginia E. Pitzer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance

Author(s) -

Samantha Kaufhold,

Reza Yaesoubi,

Virginia E. Pitzer

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy1108

Subject(s) - typhoid fever , antimicrobial , medicine , vaccination , antibiotic resistance , transmission (telecommunications) , salmonella enterica , salmonella typhi , salmonella , immunology , intensive care medicine , antibiotics , virology , biology , microbiology and biotechnology , bacteria , biochemistry , genetics , electrical engineering , escherichia coli , gene , engineering

Empiric prescribing of antimicrobials in typhoid-endemic settings has increased selective pressure on the development of antimicrobial-resistant Salmonella enterica serovar Typhi. The introduction of typhoid conjugate vaccines (TCVs) in these settings may relieve this selective pressure, thereby reducing resistant infections and improving health outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research